Cited by 37Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchGenetic Associations and Epidemiology

F1–01–01: Meta‐analysis in more than 74,000 individuals identifies 11 new susceptibility loci for Alzheimer's disease

Lambert, Jean‐Charles·2013·Alzheimer's & Dementia

Abstract

Previous genome-wide association studies (GWAS) in individuals of European ancestry identified 9 other genomic regions associated with LOAD. However, the genetic component of AD is far away to be fully characterised. The search for additional common genetic risk factors requires large-scale meta-analysis of GWAS to increase the statistical power to identify the remaining genetic variations associated with AD risk which may primarily consist of variants with small effect or rare variants. To identify new LOAD genes, we conducted under the name of I-GAP (International Genomics of Alzheimer's Project), a large two-stage genome-wide association study (GWAS) on individuals of European ancestry. For stage 1, we meta-analysed four previously published GWAS datasets consisting of 17,008 AD cases and 37,646 controls using genotyped and imputed data (7,055,881 single nucleotide polymorphisms (SNPs)). For stage 2, 11,632 SNPs (p<10–3 in stage 1) were analysed in an independent set of 8,572 AD cases and 11,312 controls. In addition to the apolipoprotein E locus, we identified 19 loci reaching genome-wide significance level (P<5x10–8) in the combined discovery and replication data of which 11 were not identified in GWAS earlier. Of note, the results from the combined Stage 1 and Stage 2 datasets also indicated 13 suggestive loci of interest (P<10–6). In summary our GWAS meta-analysis for Alzheimer's disease has identified eleven new susceptibility loci in or near plausible candidate in ad…

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2013.04.040

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Still being checked.

Cited by

Sorted by citations

Authors
Lambert, J.
Affiliations
Inserm (FR)
Corresponding author
Lambert, Jean‐Charles
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2013-07
Volume
9
Issue
4S_Part_3
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2036722142
Cited by
32
References
0
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 3 · 2019: 9 · 2018: 2 · 2017: 3 · 2015: 3 · 2014: 2 · 2013: 1
FWCI
1.39
Type
journal article
Language
en
Open access
closed
Locations
Alzheimer s & Dementia (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
Alzheimer's disease, late-onset Alzheimer's disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review